HEALTH PROFESSIONAL · SOURCE READING

Treatment Option Overview for Pheochromocytoma and Paraganglioma

Source: Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: November 1, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Limited data are available from phase II clinical trials to guide the management of patients diagnosed with pheochromocytoma or paraganglioma. There are no phase III trials. Everything is based on case series, and the impact on survival is not known.

Continue within this section

Localized and Regional Pheochromocytoma →Metastatic Pheochromocytoma →Preoperative Medical Preparation →

Preserved source evidence · Not medical advice